Longevity & Preventive Care
The science of ageing is no longer speculative. Biological clocks, senolytics, and precision diagnostics are turning longevity from a philosophical concept into a measurable, manageable clinical outcome.
2×
More healthspan years through early preventive intervention
20yrs
Max divergence between biological and chronological age
$44B
Global longevity supplement market in 2024
FOXO on Longevity
True longevity is rooted in science and grounded in everyday actions.
Biological Age Testing
Epigenetic clocks — Horvath, DunedinPACE, GrimAge — measure how fast your cells are ageing, not just how many years you've lived. Companies like TruDiagnostic and Elysium now offer consumer methylation tests that reveal your true biological age, with 6-month retests tracking whether interventions are working.
Key Insight
Biological age can diverge from chronological age by up to 20 years based on lifestyle alone.
Precision Medicine & Pharmacogenomics
Single-nucleotide polymorphisms (SNPs) in your genome determine how you metabolise drugs, respond to statins, and absorb nutrients. Precision oncology — matching tumour molecular profiles to targeted therapies — has raised 5-year survival rates in certain cancers by over 40% compared to chemotherapy alone.
Key Insight
Pharmacogenomic testing prevents ~100,000 adverse drug events in the US annually.
Senolytics & Longevity Pharmacology
Senescent cells — 'zombie cells' that stop dividing but refuse to die — drive inflammation, tissue dysfunction, and accelerated ageing. Senolytic drugs (dasatinib + quercetin, fisetin) selectively clear them. Rapamycin, NAD+ precursors (NMN, NR), and metformin are in formal longevity trials (TAME, PEARL, AgelessRx).
Key Insight
The global longevity supplements market hit $44.2B in 2024 — now science-backed protocols are entering clinical pipelines.
Preventive Diagnostics & Early Detection
Liquid biopsy (Grail Galleri, Foundation Medicine) can detect 50+ cancer types from a single blood draw years before symptoms appear. Whole-body MRI scans (Prenuvo, Ezra) screen for anomalies across organs in 45 minutes. These tools are shifting the paradigm from sick-care to pre-emptive medicine.
Key Insight
Early-stage cancer detection raises survival rates by 70–90% across most cancer types.